Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 10 Neoplasms 4 Cancer Pain 3 Pain, Postoperative 2 Malignant Female Reproductive System Neoplasm 2 Hematologic Neoplasms 2 Emergencies 2 Agnosia 2 Tumor Surgery 1 Rectal Neoplasms 1 Pulmonary Nodule 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Neoplasm Metastasis 1 Mucositis 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Intraoperative Complications 1 Ileus 1 Duodenal Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Digestive System Diseases 1 Constipation 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

aldesleukin 42 Sunitinib 39 Cyclophosphamide 30 Nivolumab 27 Everolimus 27 pembrolizumab 26 Interferon-alpha 25 Bevacizumab 22 Sorafenib 21 Interleukin-2 20 fludarabine phosphate 19 Filgrastim 18 Ipilimumab 17 Radiotherapy 16 Axitinib 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 cabozantinib 14 fludarabine 11 Radiosurgery 11 Doxorubicin 11 Carboplatin 11 temsirolimus 10 Etoposide 9 Chemotherapy, Adjuvant 9 sargramostim 8 belzutifan 8 atezolizumab 8 Fluorouracil 8 pazopanib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × Hydromorphone × Clear all

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡